Home » Products » Repaglinide Tablets 2mg | GMP Manufacturer & Supplier | Sinophare
Product Description
| Product Name | Repaglinide Tablets (Repaglinide 2mg Oral Tablets) |
| Specification | Each tablet contains: Repaglinide 2mg |
| Dosage Form | Oral Tablet (for oral administration) |
| Active Ingredient | Repaglinide |
| Pharmacological Class | Meglitinide Insulin Secretagogue (Antidiabetic Agent) |
| Route of Administration | Oral administration (swallowed whole with water; take within 30 minutes before meals, typically 15 minutes before the meal). Skip the dose if the meal is skipped. |
| Packaging | Blister pack (PVC-Alu) or HDPE bottle, typically 30 tablets per blister pack or bottle |
| Storage | Store below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze. |
| Shelf Life | 24 months (unopened) |
Product Overview
Repaglinide Tablets is an oral preparation containing Repaglinide 2mg per tablet. Repaglinide is a meglitinide-class insulin secretagogue used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is a prandial glucose regulator that is taken before meals to stimulate insulin secretion and reduce postprandial blood glucose levels. The product is formulated as oral tablets for convenient dosing before each meal.
